Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 134 (2), 405-415
- https://doi.org/10.1053/j.gastro.2007.11.036
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions PresentAntimicrobial Agents and Chemotherapy, 2007
- Expertise of Laboratories in Viral Load Quantification, Genotyping, and Precore Mutant Determination for Hepatitis B Virus in a Multicenter StudyJournal of Clinical Microbiology, 2006
- Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2006
- Detection of rtN236T and rtA181V/T Mutations Associated with Resistance to Adefovir Dipivoxil in Samples from Patients with Chronic Hepatitis B Virus Infection by the INNO-LiPA HBV DR Line Probe Assay (Version 2)Journal of Clinical Microbiology, 2006
- Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan Hepatitis B Virus (HBV) Quantitative Test and Comparison to the VERSANT HBV DNA 3.0 AssayJournal of Clinical Microbiology, 2006
- HBV drug resistance: Mechanisms, detection and interpretationJournal of Hepatology, 2006
- Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baselineJournal of Hepatology, 2005
- New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNAJournal of Hepatology, 2005
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999